Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands

Abstract Introduction The 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix) was introduced into the Dutch pediatric national immunization program (NIP) starting in 2011. However, there is substantial pneumococcal disease burden due to increases in non-PCV10 covered serotypes. Higher-valent vaccines for pediatrics (PCV13, PCV15, and PCV20) may alleviate much of the remaining disease burden upon implementation through broader serotype coverage. This article assesses the public health impact of different pediatric vaccination strategies (switching to PCV13, PCV15 or PCV20) versus mainta... Mehr ...

Verfasser: Michele Wilson
Cheryl McDade
Anna Trisia Beby-Heijtel
Angela Waterval-Overbeek
Vishalini Sundaram
Johnna Perdrizet
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: Infectious Diseases and Therapy, Vol 12, Iss 7, Pp 1809-1821 (2023)
Verlag/Hrsg.: Adis
Springer Healthcare
Schlagwörter: Pneumococcal disease / Vaccine / PCV / PCV13 / PCV20 / Infectious and parasitic diseases / RC109-216
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29173524
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1007/s40121-023-00828-8